Jefferies Group
OPTR

Jefferies Group’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Jefferies Group’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,600,000
Closed -$20.1M – 2488
2013
Q3 		$20.1M Buy
1,600,000
+1,599,865
+1,185,085% +$21.2M 0.2% 70
2013
Q2 		$2K Buy
+135
New +$1.97K ﹤0.01% 1812

Jefferies Group's OPTR Position: Q4 2013 in Review

Jefferies Group sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,600,000 shares — an estimated $20.1M sold.

Jefferies Group first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $20.1M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Jefferies Group reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Jefferies Group sold 1,600,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $20.1M.
  • Jefferies Group first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Jefferies Group's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $20.1M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Jefferies Group's 13F filing for Q4 2013, filed 18 Feb 2014.